Clinical Trial Update: Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France

View source ↗

Summary

This completed clinical trial describes saxagliptin utilization and assesses its impact on health status in patients with Type 2 Diabetes Mellitus in France.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Onglyza (Saxagliptin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus (T2D) | Status: COMPLETED